These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 28560762

  • 21. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR, Lin WY, Wu CF, Shee JJ, Huang YC, Chen CS.
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [Abstract] [Full Text] [Related]

  • 22. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S, Swift S, Guan Z, Carlsson M, Morrow JD, Brodsky M, Gong J.
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    Robinson D, Cardozo L, Terpstra G, Bolodeoku J, Tamsulosin Study Group.
    BJU Int; 2007 Oct; 100(4):840-5. PubMed ID: 17822465
    [Abstract] [Full Text] [Related]

  • 26. Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long-term, multicenter phase 3 study of desmopressin in Japanese patients.
    Juul KV, Andersson FL, Yamaguchi O.
    Low Urin Tract Symptoms; 2021 Jan; 13(1):129-138. PubMed ID: 32914581
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.
    Kaminetsky J, Fein S, Dmochowski R, MacDiarmid S, Abrams S, Cheng M, Wein A.
    J Urol; 2018 Sep; 200(3):604-611. PubMed ID: 29654805
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment.
    Ellington DR, Szychowski JM, Malek JM, Gerten KA, Burgio KL, Richter HE.
    Female Pelvic Med Reconstr Surg; 2016 Sep; 22(4):254-60. PubMed ID: 26945271
    [Abstract] [Full Text] [Related]

  • 30. Desmopressin acetate nasal spray for adults with nocturia.
    Cohn JA, Kowalik CG, Reynolds WS, Kaufman MR, Milam DF, Dmochowski RR, Wein AJ.
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1281-1293. PubMed ID: 29048257
    [Abstract] [Full Text] [Related]

  • 31. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV, Malmberg A, van der Meulen E, Walle JV, Nørgaard JP.
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [Abstract] [Full Text] [Related]

  • 32. Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuria.
    Alford N, Hashim H.
    Expert Rev Clin Pharmacol; 2021 Aug; 14(8):939-954. PubMed ID: 33993824
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gender difference in antidiuretic response to desmopressin.
    Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP.
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia.
    Ahmed AF, Maarouf A, Shalaby E, Gabr AH, Shahin A, Ghobish A.
    World J Urol; 2015 May; 33(5):649-57. PubMed ID: 25138579
    [Abstract] [Full Text] [Related]

  • 37. Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
    Chung E.
    Expert Opin Pharmacother; 2018 Feb; 19(3):291-298. PubMed ID: 29376448
    [Abstract] [Full Text] [Related]

  • 38. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Berges R, Höfner K, Gedamke M, Oelke M.
    World J Urol; 2014 Oct; 32(5):1163-70. PubMed ID: 25135845
    [Abstract] [Full Text] [Related]

  • 39. Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
    Sebastianelli A, Russo GI, Kaplan SA, McVary KT, Moncada I, Gravas S, Chapple C, Morgia G, Serni S, Gacci M.
    Int J Urol; 2018 Mar; 25(3):196-205. PubMed ID: 29205506
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D, Schneider T, Kelleher C, Van Kerrebroeck P, Swift S, Creanga D, Martire DL.
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.